| Literature DB >> 30701048 |
Vikas Chander1, Bhavtosh Sharma2, Vipul Negi3, Ravinder Singh Aswal4, Prashant Singh1, Rakesh Singh3, Rajendra Dobhal5.
Abstract
Pharmaceutical products and their wastes play a major role in the degradation of environment. These drugs have positive as well as negative consequences on different environmental components including biota in different ways. Many types of pharmaceutical substances have been detected with significant concentrations through various advanced instrumental techniques in surface water, subsurface water, ground water, domestic waste water, municipal waste water and industrial effluents. The central as well as state governments in India are providing supports by creating excise duty free zones to promote the pharmaceutical manufacturers for their production. As a result, pharmaceutical companies are producing different types of pharmaceutical products at large scale and also producing complex non-biodegradable toxic wastes byproducts and releasing untreated or partially treated wastes in the environment in absence of strong regulations. These waste pollutants are contaminating all types of drinking water sources. The present paper focuses on water quality pollution by pharmaceutical pollutants, their occurrences, nature, metabolites and their fate in the environment.Entities:
Keywords: Pharmaceutical effluent; fate and water pollution; pharmaceutical global market
Year: 2016 PMID: 30701048 PMCID: PMC6324466 DOI: 10.4081/xeno.2016.5774
Source DB: PubMed Journal: J Xenobiot ISSN: 2039-4705
Figure 1.Status of global pharmaceuticals production continent wise.
Figure 2.Statistical representation of pharmaceutical’s market situation.
Figure 3.Oxidative metabolism of ibuprofen.
Different classes and nature of pharmaceutical drugs.
| Pharmaceutical classes | Pharmaceutical drugs | Nature of pharmaceutical drug |
|---|---|---|
| Anti-inflammatory | Aspirin | Hydrophilic |
| Diclofenac | Varies | |
| Ibuprofen | Moderate hydrophobic | |
| Lipid regulators | Clofibric acid | Moderate hydrophobic |
| Bezafibrate | Hydrophobic | |
| Fenofibric acid | Hydrophobic | |
| Antiepileptics | Carbamazepine | Moderate hydrophobic |
| β–blockers | Metoprolol | Hydrophilic |
| Antibiotics | Ciprofloxacin | Hydrophilic |
Pharmaceutical compounds with detected concentrations in different water bodies with their extraction methods.
| Pharmaceutical compound | Concentration | Extraction method | Instrument used | Country | References | |
|---|---|---|---|---|---|---|
| Ground water | ||||||
| Acetaminophen | 1.89 mg/L | Solid phase extraction | HPLC-MS | USA | 42 | |
| Caffeine | 0.29 mg/L | |||||
| Carbamazepine | 0.42 mg/L | |||||
| Codeine | 0.214 mg/L | |||||
| P-xanthine | 0.12 mg/L | |||||
| Sulfamethoxazole | 0.17 mg/L | |||||
| Trimethoprim | 0.018 mg/L | |||||
| Surface water | ||||||
| Ibuprofen | 414 ng/L | Solid phase extraction using high performance extraction disks (SBD-XD) | HPLC with tandem MS | South Korea | 43 | |
| Carbamazepine | 595 ng/L | |||||
| Atenolol | 690 ng/L | |||||
| Clarithromycin | 443 ng/L | |||||
| Mefenamic acid | 326 ng/L | |||||
| Erythromycin | 137 ng/L | |||||
| Fluconazole | 111 ng/L | |||||
| Levofloxacin | 87.4 ng/L | |||||
| Indomethacin | 33.5 ng/L | |||||
| Propranolol | 40.1 ng/L | |||||
| Ifenprodil | 35.4 ng/L | |||||
| Finofibric acid | 3.20 mg/L | Oasis HLB solid phase extraction | Reverse Phase HPLC through diode array detector with C18 column | Douro River Estuary | 44 | |
| Carbamazepine | 0.60 mg/L | |||||
| Diazepam | 1.60 mg/L | |||||
| Fluoxetine | 32.00 mg/L | |||||
| Propranolol | 0.80 mg/L | |||||
| Sulfamethoxazole | 1.40 mg/L | |||||
| Trimethoprim | 8.00 mg/L | |||||
HPLC-MS, high-performance liquid chromatography coupled with mass spectrometry; SBD
Detection of pharmaceuticals in fresh water samples in Hyderabad area, India.
| Drug | Lakes(03 sampling sites of 02 lakes) | River (06 sampling points) | Wells (06 wells) |
|---|---|---|---|
| Norfloxacin | 60,000-520,000 | ND-4700 | ND-31 |
| Ciprofloxacin | ND-6,500,000 | 10,000-2,500,000 | 44-14,000 |
| Ofloxacin | ND-11,000 | 180-10,000 | ND-480 |
| Enoxacin | 14,000-160,000 | ND-66,000 | ND-1900 |
| Enrofloxacin | ND-25,000 | ND-30,000 | ND-67 |
| Metoprolol | 7000-ND | ND-240 | ND-90 |
| Cetirizine | 5000-1,200,000 | 5,400-530,000 | 550-28,000 |
| Citalopram | 2000-8000 | ND-76,000 | ND-1400 |
ND, not detected.
Physico-chemical characteristics in pharmaceutical industrial effluents.
| S. No. | Characteristics | Unit | Ref. 48 | Ref. 52 | Ref. 53 | Ref. 54 |
|---|---|---|---|---|---|---|
| 1. | pH | - | 5.1 | 12.54 | 10.34 | 8.00 |
| 2. | Temperature | °C | 29.8 | - | 36.34 | 28.87 |
| 3. | Conductivity | mS/cm | - | 27,400 | 1534.21 | 1733.13 |
| 4. | TSS | mg/L | 654 | 2980 | 2673.22 | 348.75 |
| 5. | TDS | mg/L | 3412.5 | 8741 | 2655.43 | 873.81 |
| 6. | DO | mg/L | - | 3.50-4.70 | 8.43 | 5.78 |
| 7. | BOD | mg/L | 1083.5 | 546 | 341.11 | 52.13 |
| 8. | COD | mg/L | 2797.3 | 1271 | 698.11 | 218.42 |
TSS, total suspended solid; TDS, total dissolved solid; DO, dissolved oxygen; BOD, biochemical oxygen demand; COD, chemical oxygen demand.
Concentrations of heavy metals in pharmaceutical industrial effluents.
| S. No. | Characteristics | Unit | Ref. 49 | Ref. 52 | Ref. 55 | Ref. 56 |
|---|---|---|---|---|---|---|
| 1. | Chromium | mg/L | 30.6 | 0.57 | 2.34 | 0.31 |
| 2. | Cadmium | mg/L | 35.8 | - | ND | 0.55 |
| 3. | Nickel | mg/L | 33.6 | 0.43 | - | 0.12 |
| 4. | Zinc | mg/L | 26.8 | 3.31 | - | 1.3 |
| 5. | Copper | mg/L | 17.6 | 14.06 | 2.30 | 0.38 |
| 6. | Lead | mg/L | 21.7 | 0.42 | ND | 0.263 |
| 7. | Iron | mg/L | 10.4 | 18.93 | 19.38 | 19.38 |
ND, not detected.